These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
471 related items for PubMed ID: 17189101
1. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Araujo R, Pina-Vaz C, Rodrigues AG. Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101 [Abstract] [Full Text] [Related]
7. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Öz Y, Özdemir HG, Gökbolat E, Kiraz N, Ilkit M, Seyedmousavi S. Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621 [Abstract] [Full Text] [Related]
9. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex. Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, Dolatabadi S, Mirhendi H. Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417 [Abstract] [Full Text] [Related]
13. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, Ruiz J, Chidambaram JD, Maxey KJ, Hong KC, McLeod SD, Lietman TM. Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990 [Abstract] [Full Text] [Related]
14. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species. Misra R, Malik A, Singhal S. Indian J Pathol Microbiol; 2011 Jun; 54(1):112-6. PubMed ID: 21393890 [Abstract] [Full Text] [Related]